Jorma Routti
CIK 1621330 · last filed 2019-03-27
Jorma Routti is a corporate insider who has filed 17 SEC Form 4 insider transactions across 1 company since 2014. The most recent filing shows the insider exercised options covering $682.4K of FGEN on Mar 27, 2019. Across all open-market trades the lifetime net is −$3.8M, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
FGEN price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
409 ILLINOIS ST.,
SAN FRANCISCO, CA 94158
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| KYNTRA BIO, INC. (FGEN) Delisted | Director | 5,982 | $9.75 | $58.3K | -$3.82M | 17 | 2019-03-27 |
Recent Filings
17 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-03-27 | KYNTRA BIO, INC. (FGEN) Delisted | Exer (M) | +30,000 | $682.4K | EDGAR |
| 2018-09-12 | KYNTRA BIO, INC. (FGEN) Delisted | Mixed | — | -$233.8K | EDGAR |
| 2018-08-10 | KYNTRA BIO, INC. (FGEN) Delisted | Mixed | — | -$251.6K | EDGAR |
| 2018-07-11 | KYNTRA BIO, INC. (FGEN) Delisted | Mixed | — | -$298.3K | EDGAR |
| 2018-06-12 | KYNTRA BIO, INC. (FGEN) Delisted | Mixed | — | -$286.2K | EDGAR |
| 2018-06-07 | KYNTRA BIO, INC. (FGEN) Delisted | Grant (A) | +3,700 | $0 | EDGAR |
| 2018-05-11 | KYNTRA BIO, INC. (FGEN) Delisted | Mixed | — | -$223.9K | EDGAR |
| 2018-04-11 | KYNTRA BIO, INC. (FGEN) Delisted | Mixed | — | -$243.9K | EDGAR |
| 2018-02-16 | KYNTRA BIO, INC. (FGEN) Delisted | Mixed | — | -$621.6K | EDGAR |
| 2017-12-04 | KYNTRA BIO, INC. (FGEN) Delisted | Mixed | — | -$532.2K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.